Kenji Kurazono

5PUBLICATIONS
10CO-AUTHORS
Counselling, wellbeing and community servicesEconomic development policyPharmacogenomicsOccupational epidemiologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 31, 2025
Willingness to pay for the effect of SARS-CoV-2 antivirals in preventing COVID-19 transmission to others in the Japanese population.

Ataru Igarashi, Kenji Kurazono, Naoya Itsumura

|Jun 14, 2023
Preferences and values for government policies on infectious disease outbreaks and epidemics for the Japanese population: a conjoint analysis.

Ippei Morita, Kenji Kurazono, Manami Yoshida

|Jun 11, 2023
Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan.

Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono

|Nov 29, 2021
Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals: a questionnaire survey in Japan.

Kenji Kurazono, Hidetoshi Ikeoka, Shinzo Hiroi

|Aug 13, 2021
A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan.

Norikane Miki, Sachie Inoue, Hidetoshi Shibahara

Pageof 1

Frequent Collaborators

4 joint publications

Tomomi Takeshima

3 joint publications

Shinzo Hiroi

2 joint publications

Ataru Igarashi

1 joint publications

Sachie Inoue